• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cost-effectiveness of annual targeted larvicid campaigns in Cambodia against dengue

Sally Furniss

Well-known member
Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti

http://envirovaluation.org/index.php/2007/09/16/tropical_medicine_a_international_health

Summary:

Objective
To assess the cost-effectiveness (CE) of annual targeted larviciding campaigns from 2001 to 2005 against the dengue vector Aedes aegypti in two urban areas of Cambodia with a population of 2.9 million people.

Methods The intervention under analysis consisted of annual larviciding campaigns targeting medium to large water storage containers in households and other premises. The CE compared the intervention against the hypothetical alternative of no intervention. The CE was calculated as the ratio of disability adjusted life years (DALYs) saved to the net cost of the intervention (in 2005 US dollars) by year. A sensitivity analysis explored the range of study parameters.

Results The intervention reduced the number of dengue cases and deaths by 53%. It averted an annual average of 2980 dengue hospitalizations, 11 921 dengue ambulatory cases and 23 dengue deaths, resulting in a saving of 997 DALYs per year. The gross cost of the intervention was US$ 567 800 per year, or US$ 0.20 per person covered. As the intervention averted considerable medical care, the annual net cost of the intervention was US$ 312 214 (US$ 0.11 per person covered) from a public sector perspective and US$ 37 137 (US$ 0.01 per person covered) from a societal perspective. The resulting CE ratios were: US$ 313/DALY gained from the public perspective and US$ 37/DALY gained from the societal perspective. Even under the most conservative assumption, the intervention remained cost effective from both perspectives.

Conclusions Annual, targeted larviciding campaigns appear to have been effective and cost-effective medium-term interventions to reduce the epidemiologic and economic burden of dengue in urban areas of Cambodia.

by Jose A. Suaya 1, Donald S. Shepard 1, Moh-Seng Chang 2, Mariana Caram 1, Stefan Hoyer 1, Duong Socheat 3, Ngan Chantha 3 and Michael B. Nathan 4
1. Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, MA, USA; Telephone: +1 781 736 3904; Fax: +1 775 522 0674; E-mail: suaya@brandeis.edu
2. WHO, Phnom Penh, Cambodia,
3. National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia,
4. WHO Liaison Officer and Malaria Adviser to the International Federation of Red Cross and Red Crescent Societies
 
Back
Top